BioLine RX Ltd (NASDAQ:BLRX)

2.50
Delayed Data
As of Jul 02
 -0.15 / -5.66%
Today’s Change
1.20
Today|||52-Week Range
3.28
+54.32%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for BioLine RX Ltd have a median target of 8.00, with a high estimate of 10.50 and a low estimate of 5.00. The median estimate represents a +220.00% increase from the last price of 2.50.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in BioLine RX Ltd. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.08
Sales
$0.00
Reporting Date
Aug 25

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 16.67%
 
 
 
 
 
 
Growthannually 7.58%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account